文献速递认知障碍与痴呆

早发型与晚发型散发性阿尔茨海默病的淀粉样蛋白PET比较

Amyloid PET in Sporadic Early- Versus Late-Onset Alzheimer's Disease: Comparison of the LEADS and ADNI Cohorts.
PubMed 文献 · Ann Neurol · 2025-03-17

LEADS队列的淀粉样蛋白阳性率高于ADNI队列,且视觉阳性扫描的Centiloids(CLs)值在EOAD中更高,尤其在顶叶/楔前叶、颞上回和额叶皮层。女性在兩队列中CLs均更高,APOE4携带与EOAD中更低的CLs相关,而CLs与MMSE的相关性在EOAD中更强。

要点

  • LEADS队列淀粉样蛋白阳性率78%高于ADNI队列71%。
  • 视觉阳性扫描的CLs在EOAD中更高(95.3 vs 80.9)。
  • 女性在兩队列中CLs均更高,APOE4携带与EOAD中更低CLs相关。

核心结论

  • 淀粉样蛋白病理负荷的差异可能 contribute to 散发性EOAD和LOAD的临床和解剖模式差异,并对优化各组治疗策略有启示。

主要发现

  • 淀粉样蛋白阳性率LEADS为78%(95%CI=74-82),ADNI为71%(95%CI=67-75),p=0.02。
  • 视觉阳性扫描的CLs在LEADS中(EOAD,均值=95.3±26.1)高于ADNI中(LOAD,均值=80.9±36.8),p<0.0001,主要位于顶叶/楔前叶、颞上回和额叶皮层。
  • 在淀粉样蛋白阳性患者中,兩队列女性CLs均更高;APOE4携带与EOAD中更低的CLs相关,而LOAD中未观察到;CLs与MMSE评分的相关性在EOAD中显著强于LOAD。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Early-onset Alzheimer's disease (EOAD) and late-onset Alzheimer's disease (LOAD) differ in many respects. Here, we address the issue of possible differences in fibrillar amyloid pathology as measured by positron emission tomography (PET), which remains unresolved due to the lack of large-scale comparative studies. METHODS: Three hundred ninety-nine cognitively impaired participants younger than 65 years of age from the multicenter Longitudinal Early-onset Alzheimer's Disease Study (LEADS) and 450 cognitively impaired participants older than 65 years from the Alzheimer's Disease Neuroimaging Initiative (ADNI) underwent clinical assessment, brain magnetic resonance imaging (MRI), and amyloid PET and were included in this study. We compared amyloid PET outcomes (positivity rate based on visual read and quantified tracer uptake expressed as Centiloids [CLs]) between the 2 cohorts and studied their association with age, sex, APOE genotype, and cognition. RESULTS: The amyloid positivity rate was higher in LEADS (78%, 95% confidence interval [CI] = 74-82) than in ADNI (71%, 95% CI = 67-75, p = 0.02). Lower Mini-Mental State Examination (MMSE) and APOE4 genotype increased the odds of amyloid positivity in both cohorts. Visually positive scans had higher CLs in LEADS (EOAD, mean = 95.3 ± 26.1) than in ADNI (LOAD, mean = 80.9 ± 36.8, p < 0.0001), predominantly in parietal cortex/precuneus, superior temporal, and frontal cortices. In amyloid-positive patients, (1) CLs were higher in female patients in both cohorts; (2) APOE4 carriership was associated with lower CLs in EOAD, which was not observed in LOAD; and (3) correlations between CLs and MMSE scores were significantly stronger in EOAD than in LOAD. INTERPRETATION: Differences in the burden of amyloid pathology may contribute to differences in clinical and anatomic patterns in sporadic EOAD and LOAD, and have implications for optimizing therapeutic strategies in each group. ANN NEUROL 2025;98:236-248.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Lagarde J, Maiti P, Schonhaut DR, et al. Amyloid PET in Sporadic Early- Versus Late-Onset Alzheimer's Disease: Comparison of the LEADS and ADNI Cohorts. Ann Neurol. 2025. PMID: 40091774. doi:10.1002/ana.27233

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。